Table 7 Definition of Metabolic Syndrome (MS)
From: Metabolic syndrome in South Asian immigrants: more than low HDL requiring aggressive management
IDF (2005) | NCEP ATP III (2001) | European Group (1999) | WHO 1999 | |
|---|---|---|---|---|
Central obesity (ethnicity-specific)‡ and two or more of the following: | Three or more of the following: | Non-diabetics with insulin resistance§ and two or more of the following: | T2 D, impaired glucose tolerance, impaired fasting glucose, or insulin resistance* plus two or more of the following: | |
Glucose (fasting) | ≥100 mg/dL (5.6 mmol/L) or T2D | ≥110 mg/dL (6.1 mmol/L)† | ≥110 mg/dL (6.1 mmol/L), but non-diabetic | |
Obesity | Central obesity (ethnicity-specific)‡ | Waist circumference ≥102 cm (40 in) in males or ≥ 88 cm (35 in) in females | Waist circumference ≥ 94 cm (37.0 in) in males or ≥ 80 cm (31.5 in) in females | Central obesity (WHR ≥ 0.90 in males or ≥ 0.85 in females) and/or BMI ≥ 30 kg/m2 |
HDL Levels | ≥ 40 mg/dL (1.03 mol/L) in males, ≥ 50 mg/dL (1.29 mmol/L) in females, or treatment | ≥ 40 mg/dL (1.03 mmol/L) in males or ≥ 50 mg/dL (1.29 mmol/L) in females | ≥ 39 mg/dL (1.0 mmol/L) or treatment | ≥ 35 mg/dL (0.9 mmol/L) in males or ≥ 39 mg/dL (≥ 1.0 mmol/L) in females |
Blood Pressure | ≥130/≥85 mmg or treatment | ≥140/90 mm Hg or treatment | ≥140/90 mm Hg or treatment | ≥140/90 mm Hg |
Triglycerides | ≥150 mg/dL (1.7 mmol/L) or treatment | ≥150 mg/dL (1.7 mmol/L) | ≥150 mg/dL (1.7 mmol/L) or treatment | ≥178 mg/dL (2.0 mmol/L) or treatment |